This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 10

Based on the information you provided, we found the following studies.

  • A First-In-Human Study of Dosing with REGN2810 as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies Study purpose: find safe dose of REGN2810 given alone or in combination therapies;measure levels of REGN2810 in blood; evaluate if REGN2810 given alone or in combination w/other therapies will cause tumor shrinkage;test different dose levels of REGN2810, radiotherapy, GM-CSF, and cyclophosphamide. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Stomach cancer, Gastric cancer ( Malignant tumor of stomach ) Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of Investigational Drug INCB054828 in Subjects with Advanced Malignancies Study goals: determine dose that is safe and tolerable in people with advanced cancer and select the doses that will be studied further; see how INCB054828 acts on and in the body; see effect INCB054828 has on the growth of your cancer; see action of INCB054828 in the body over a period of time This study is researching all of the following topics: Bladder cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Multiple myeloma Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase Ib and Phase II Studies of anti-PD-1 Antibody Pembrolizumab (MK-3475) in Combination with Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma This study is being done to find out if adding pembrolizumab to bevacizumab does a better job at killing cancer. This study will allow the researchers to know whether adding pembrolizumab is better, the same, or worse than the usual approach. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Randomized Ph 2 Trial of Axitinib and investigational drug TRC105 Versus Axitinib Alone (Including lead-in Ph 1B Dose Escalation Portion) in Patients With Advanced or Metastatic Renal Cell Carcinoma Study purpose: determine the effectiveness and safety of the TRC105 monoclonal antibody when given in combination with axitinib vs. axitinib alone, and to assess how well you tolerate the combination. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1 Trial of SGN-CD70A in Patients with CD70-Positive Malignancies Investigational drug SGN-CD70A is being studied to evaluate the side effects of SCN-CD70A and what dose is safe.This study will evaluate how SGN-CD70A works against renal cell carcinoma (RCC) (kidney cancer) or non-Hodgkin’s lymphoma (NHL).This is the first time SGN-CD70A will be given to people. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Prometheus, the sponsor, has established a Registry to collect information on patients who are receiving treatment with Proleukin for metastatic Renal Cell Carcinoma, metastatic Melanoma, or other malignancies, in an organized way to learn more about patient care during and after treatment. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) Melanoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase II Randomized Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for the Treatment of Localized Renal Cell Carcinoma The purpose of this study is to compare the effects of two treatment methods: radiofrequency ablation (RFA), a minimally invasive technique, and stereotactic body radiation therapy (SBRT), a non-invasive option, on small renal cell carcinoma. This study is researching all of the following topics: Kidney Cancer ( Malignant tumor of kidney ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old